Critically evaluate the role of the judiciary in pushing regulators to act on public health, with reference to the front-of-pack labelling case.

The Supreme Court has read the right to health into Article 21 (Paschim Banga Khet Mazdoor Samiti, 1996). A PIL filed by 3S and Our Health Society is testing how far the courts should enforce that right. In it, the Court questioned FSSAI's timeline of nearly two years for front-of-pack labels (FoPL) warning buyers about foods high in sugar, salt and saturated fat [1]. The judiciary has been a necessary spur here, but its role has limits.

Positive role: judiciary as an accountability trigger

• Breaking regulatory inertia: FSSAI began work on FoPL in 2022. The Bench asked, "What did you do in the last four years?" [1]
• Checking dilution: The Court questioned a voluntary compliance year [1]. Under voluntary rules, the least healthy products have the least reason to carry a label.
• Rights-based framing: The Court said citizens' health outweighs yet another round of consultation [1]. Courts have pushed regulators before too, as in the M.C. Mehta CNG orders on Delhi's buses.
• Countervailing pressure: FSSAI's 2022 study favoured a Health Star Rating [2]. That is a single overall score, so it does not tell the buyer which nutrient is too high. Court scrutiny keeps attention on whether FSSAI's final choice of label format actually serves consumers.

Limits and risks

• Technical competence: Setting nutrient thresholds and designing labels needs expert panels. Judges do not have that expertise.
• Separation of powers: When a court fixes a regulator's rule-making schedule, it moves into the executive's domain.
• Procedural fairness: Consultation gives small food businesses a voice. FSSAI said its 365-day transition was meant to cause "minimal hardship" [1]. Rules made in a hurry are also easier to challenge in court.
• Speed vs substance: A deadline on its own could simply produce a faster star-rating system rather than the warning labels the PIL seeks [1][2].

Calibrated judicial role

• The Court should fix deadlines and demand reasons for delay, and leave the thresholds to FSSAI's scientific panels.
• It can point to evidence from abroad. Argentina, Chile, Mexico, Peru and Uruguay use black octagon warnings, which help consumers identify unhealthy products most easily [3].
• The transition should be mandatory with a fixed end date, not voluntary.

Overall, the FoPL case shows the judiciary working best as a catalyst for accountability, not a substitute regulator. The balanced path is court-set timelines combined with evidence-based rules made by FSSAI. That approach supports the State's duty under Article 47 to improve public health and India's commitment under SDG 3.4 to cut early deaths from NCDs such as diabetes and heart disease, while still respecting the separation of powers.